scispace - formally typeset
Z

Zeyao Li

Researcher at Tsinghua University

Publications -  12
Citations -  526

Zeyao Li is an academic researcher from Tsinghua University. The author has contributed to research in topics: Candida albicans & Nucleic acid. The author has an hindex of 6, co-authored 12 publications receiving 300 citations.

Papers
More filters
Journal ArticleDOI

Comparative Analysis of Droplet-Based Ultra-High-Throughput Single-Cell RNA-Seq Systems.

TL;DR: Three widely used droplet-based ultra-high-throughput single-cell RNA-seq systems, inDrop, Drop-seq, and 10X Genomics Chromium are developed and detailed comparison revealed the distinguishing features and suitable applications for each system.
Journal ArticleDOI

Candida albicans gains azole resistance by altering sphingolipid composition.

TL;DR: It is found that null mutants in either gene FEN1 or FEN12 exhibit resistance to fluconazole, a first-line antifungal drug, and the new transposon-mediated mutagenesis system should facilitate future genome-wide studies of C. albicans.
Journal ArticleDOI

Mapping spatial transcriptome with light-activated proximity-dependent RNA labeling.

TL;DR: A light-activated RNA labeling method was developed to determine spatial organization of a transcriptome and found that ribosomal proteins and oxidative phosphorylation pathway proteins are highly enriched at the outer mitochondrial membrane.
Journal ArticleDOI

Expanding APEX2 Substrates for Proximity-Dependent Labeling of Nucleic Acids and Proteins in Living Cells.

TL;DR: APEX2-mediated Btn-An labeling of RNA is thus a promising method for mapping the subcellular transcriptome, which could shed light on their functions in cell physiology.
Journal ArticleDOI

Mutant Kras co-opts a proto-oncogenic enhancer network in inflammation-induced metaplastic progenitor cells to initiate pancreatic cancer

TL;DR: It is shown that pancreatic inflammation is coupled to the emergence of a transient progenitor cell population that is readily transformed in the presence of mutant KrasG12D, providing an oncogenic transcriptional program that fuels tumor progression beyond initiation, accounting for the intra-tissue selectivity of Kras transformation.